Concepedia

QiJiong Li

QL

25

Publications

1.8K

Citations

19

H-Index

2015

Active since

Affiliations

Sun Yat-sen University Cancer Center(Current)

Sun Yat-sen University

State Key Laboratory of Oncology in South China

Twelfth Guangzhou City People's Hospital

First People's Hospital of Foshan

QiJiong Li is an author at Sun Yat-sen University Cancer Center specializing in medicine, hepatology, and hepatocellular carcinoma.

ORCID

Top concepts

Publications per year

2015–2024

25

Publications

25

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

Minke He, QiJiong Li, Ruhai Zou et al. · JAMA Oncology · 2019 · 519 citations · Full text

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

Minke He, Run-Bin Liang, Yang Zhao et al. · Therapeutic Advances in Medical Oncology · 2021 · 206 citations · Full text

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Minke He, Yong Le, QiJiong Li et al. · Chinese Journal of Cancer · 2017 · 153 citations · Full text

Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial

ZhiCheng Lai, Minke He, Xiaoyun Bu et al. · European Journal of Cancer · 2022 · 141 citations

, , +11

NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity

QiJiong Li, Xiaofeng Liu, Kemin Jin et al. · BMC Cancer · 2017 · 107 citations · Full text

Rows per page

1–5 of 25